(Q36922393)

17 August 2017

1 reference

title

Helicobacter and gastric malignancies (English)

1 reference

17 August 2017

2

Peter Malfertheiner

1 reference

17 August 2017

Steven F Moss

1

1 reference

17 August 2017

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

12 Suppl 1

1 reference

17 August 2017

23-30

1 reference

The global health burden of infection-associated cancers in the year 2002

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Antibiotic treatment and risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Intracellular Helicobacter pylori in gastric epithelial progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Demonstration and characterization of mutations induced by Helicobacter pylori organisms in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Interleukin-1 polymorphisms associated with increased risk of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

The pathogenesis of MALT lymphomas: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

The Helicobacter pylori virulence factor CagA promotes Erk1/2-mediated Bad phosphorylation in lymphocytes: a mechanism of CagA-inhibited lymphocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2007.00539.X

10.1111/J.1523-5378.2007.00539.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17727457